Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Prevalence of Functional Lower Urinary Tract Voiding Dysfunction in School-Aged Children

NCT07067957 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-07-10
Last updated
2025-07-16

Condition(s) studied

Voiding DysfunctionUrinary IncontinenceUrination DisordersLower Urinary Tract SymptomsPediatricsConstipation

Investigational drug(s) / intervention(s)

Arabic Dysfunctional Voiding Symptom Score Questionnaire (DVSS)

Arabic Dysfunctional Voiding Symptom Score Questionnaire (DVSS): A validated Arabic version of the Dysfunctional Voiding Symptom Score Questionnaire (DVSS) questionnaire will be used to screen children for symptoms of lower urinary tract dysfunction. It includes 10 items assessing urinary and bowel habits.

Study summary

The aim of this study is to investigate the prevalence of voiding disorders and the related risk factors for the primary school-age children in El Ghrbia Government

Eligibility

Sex
ALL
Min age
4 Years
Max age
14 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged 4-14 years old in our locality. Exclusion Criteria: * Children with known anatomical anomalies of urinary tract * Children with known neurological anomalies (spinal dysraphism, multiple sclerosis, lumbar or spinal neuritis……… etc) * Children with history of back or lower urinary tract trauma * Parents who refuse participation

Primary outcome measure(s)

  • Prevalence of Voiding Dysfunction — 1 Hour after completion of the questionnaire
    Prevalence of Voiding Dysfunction Among School-Aged Children will be Measured using the validated Arabic version of the Dysfunctional Voiding Symptom Score (DVSS). Children with a score above the diagnostic threshold will be considered as having voiding dysfunction.

Trial sites (1)

FacilityCityRegionStatus
Tanta University Tanta El-Gharbia
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07067957 on ClinicalTrials.gov ↗ ← All trials in Egypt